Clinical research progress in hypertriglyceridemic acute pancreatitis. [J]. Journal of Southwest Medical University 45(1):17-20(2022)
DOI:
Clinical research progress in hypertriglyceridemic acute pancreatitis. [J]. Journal of Southwest Medical University 45(1):17-20(2022) DOI: 10.3969/j.issn.2096-3351.2022.01.004.
Clinical research progress in hypertriglyceridemic acute pancreatitis
Hypertriglyceridemic acute pancreatitis (HTG-AP) is acute pancreatitis caused by severe hypertriglyceridemia (HTG), which is characterized by high severity, high relapse rate and increasing incidence in young individuals. With the improvement of living standards, the incidence of HTG-AP has been increasing every year, and clinical research on HTG-AP has attracted much attention. In this paper, we summarize the clinical research progress in HTG-AP and prospect the future research in this field.
Progress in the study of digestive system diseases in 2021
Related Author
LU Lungen
SHEN Bo
XIAO Li
CHEN Min
YAO Xiaodong
KANG Li
DENG Gao
WANG Dan
Related Institution
Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Department of Traditional Chinese Medicine,the Third People’s Hospital of Chengdu
Department of T.C.M Basis,the Affiliated Hospital of T.C.M,College of integration traditional Chinese and Western Medicine of Southwest Medical University
Department of General Surgery,the Third People’s Hospital of Chengdu